PP2Cγ-mediated S-phase accumulation induced by the proteasome-dependent degradation of p21WAF1/CIP1

FEBS Letters

Volumn 580, Issue 26, 2006, Pages 6100-6104

  Suh, Eun Jung ^a   Kim, Tae Yoon ^b   Kim, Sang Hoon ^a  

^a Kyung Hee University   (South Korea)

^b The Catholic University of Korea   (South Korea)

Author keywords

Cell cycle; p21WAF1 CIP1; PP2C ; Proteasome; S phase arrest

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1; PHOSPHOPROTEIN PHOSPHATASE; PROTEASOME; PROTEIN PP2CGAMMA; UNCLASSIFIED DRUG; CDKN1A PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; PHOSPHATASE; PHOSPHOPROTEIN PHOSPHATASE 2C;

ARTICLE; CELL CYCLE; CELL CYCLE S PHASE; CELL SYNCHRONIZATION; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVITY; ENZYME RELEASE; HUMAN; HUMAN CELL; MAMMAL CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; CELL LINE; FLOW CYTOMETRY; GENETIC TRANSFECTION; GENETICS; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; WESTERN BLOTTING;

MAMMALIA;

BLOTTING, WESTERN; CELL CYCLE; CELL LINE; CYCLIN-DEPENDENT KINASE INHIBITOR P21; FLOW CYTOMETRY; HUMANS; PHOSPHOPROTEIN PHOSPHATASE; PHOSPHORIC MONOESTER HYDROLASES; PHOSPHORYLATION; PROTEASOME ENDOPEPTIDASE COMPLEX; S PHASE; TRANSFECTION;

EID: 33750494172     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2006.10.005     Document Type: Article

References (23)

1. Schonthal A.H. Role of serine/threonine protein phosphatase 2 in cancer. Cancer Lett. 170 (2001) 1-13
2. Cheng A., Kaldis P., and Solomon M.J. The effects of changing the site of activating phosphorylation in CDK2 from threonine to serine. J. Biol. Chem. 275 (2000) 34744-34749
3. Cohen P. The structure and regulation of protein phosphatases. Annu. Rev. Biochem. 58 (1989) 453-508
4. Shenolikar S., and Nairn A.C. Protein phosphatases: recent progress. Adv. Second Messenger Phosphoprot. Res. 23 (1991) 1-121
5. Tong Y., Quirion R., and Shen S.H. Cloning and characterization of a novel mammalian PP2C isozyme. J Biol. Chem. 25 (1998) 35282-35290
6. Jin F., Ji C., Liu L., Dai J., Gu S., Sun X., Xie Y., and Mao Y. Molecular cloning and characterization of a novel human protein phosphatase 2 C cDNA (PP2C epsilon). Mol. Biol. Rep. 31 (2004) 197-202
7. Cheng A., Ross K.E., Kaldis P., and Solomon M.J. Dephosphorylation of cyclin-dependent kinases by type 2C protein phosphatases. Genes Dev. 13 (1999) 2946-2957
8. De Smedt V., Poulhe R., Cayla X., Dessauge F., Karaiskou A., Jessus C., and Ozon R. Thr-161 phosphorylation of monomeric Cdc2. Regulation by protein phosphatase 2C in Xenopus oocytes. J. Biol. Chem. 277 (2002) 28592-28600
9. Berndt N. Protein dephosphorylation and the intracellular control of the cell number. Front Biosci. 4 (1999) 22-42
10. Taylor B.K., Stoops T.D., and Everett A.D. Protein phosphatase inhibitors arrest cell cycle and reduce branching morphogenesis in fetal rat lung cultures. Am. J. Physiol. Lung Cell Mol. Physiol. 278 (2000) L1062-L1070
11. Trinkle-Mulcahy L., Andrews P.D., Wickramasinghe S., Sleeman J., Prescott A., Lam Y.W., Lyon C., Swedlow J.R., and Lamond A.I. Time-lapse imaging reveals dynamic relocalization of PP1gamma throughout the mammalian cell cycle. Mol. Biol. Cell. 14 (2003) 107-117
12. Murray M.V., Kobayashi R., and Krainer A.R. The type 2C Ser/Thr phosphatase PP2Cgamma is a pre-mRNA splicing factor. Genes Dev. 13 (1999) 87-97
13. Guthridge M.A., Bellosta P., Tavoloni N., and Basilico C. FIN13, a novel growth factor-inducible serine-threonine phosphatase which can inhibit cell cycle progression. Mol. Cell. Biol. 17 (1997) 5485-5498
14. Rousseau D., Cannella D., Boulaire J., Fitagerald P., Fotedar A., and Foterdar R. Growth inhibition by CDK-cyclin and PCNA binding domains of p21 occurs by distinct mechanisms and is regulated by ubiquitin-proteasome pathway. Oncogene 18 (1999) 3290-3302
15. Ogryzko V.V., Wong P., and Howard B.H. WAF1 retards S-phase progression primarily by inhibition of cyclin-dependent kinases. Mol. Cell. Biol. 17 (1997) 4877-4882
16. Rousseau D., Cannella D., Boulaire J., Fitzgerald P., Fotedar A., and Fotedar R. Growth inhibition by CDK-cyclin and PCNA binding domains of p21 occurs by distinct mechanisms and is regulated by ubiquitin-proteasome pathway. Oncogene 18 (1999) 1413-4325
17. Chen X., Chi Y., Bloecher A., Aebrsold R., Clurman B.E., and Roberts J.M. N-acetylation and ubiquitin-independent proteasomal degradation of p21(Cip1). Mol. Cell 16 (2004) 839-847
18. Gottifredi V., McKinney K., Poyurovsky M.V., and Prives C. Decreased p21 levels are required for efficient restart of DNA synthesis after S phase block. J. Biol. Chem. 279 (2004) 5802-5810
19. Touitou R., Richardson J., Bose S., Naknishi M., Rivett J., and Allday M.J. A degradation signal located in the C-terminus of p21WAF1/CIP1 is a binding site for the C8 alpha-subunit of the 20S proteasome. EMBO J. 20 (2001) 2367-2375
20. Hao B., Zheng N., Schulman B.A., Wu G., Miller J.J., Pagano M., and Pavletich N.P. Structural basis of the Cks1-dependent recognition of p27(Kip1) by the SCF(Skp2) ubiquitin ligase. Mol. Cell 20 (2005) 9-19
21. Nakayama K.I., and Nakayama K. Regulation of the cell cycle by SCF-type ubiquitin ligases. Semin. Cell Dev. Biol. 33 (2005) 323-333
22. Bornstein G., Bloom J., Sitry-Shevah D., Nakayama K., Pagano M., and Hershko A. Role of the SCFskp2 ubiquitin ligase in the degradation of p21Cip1 in S phase. J. Biol. Chem. 278 (2003) 25752-25757
23. Wang W., Nacusi L., Sheaff R.J., and Liu X. Ubiquitination of p21Cip1/WAF1 by SCFSkp2: substrate requirement and ubiquitination site selection. Biochemistry 44 (2005) 14553-14564